Spinal Cord Cavernous Malformation Case Review & Treatment Pathway Coordination

• Date and manner of diagnosis.
• Exact onset and progression of weakness, numbness, pain, gait or hand-function change.
• Acute, stepwise or gradually progressive course.
• Documented sensory level, reflexes, spasticity and proprioception.
• Bladder, bowel and sexual-function history.
• Recovery after each suspected haemorrhagic event.
• Current walking distance, aids, transfers and independence.
• Patient-defined priorities and functions they most need to preserve or regain.

• Original DICOM files and formal radiology reports.
• Sagittal and axial T1- and T2-weighted sequences.
• GRE, SWI or another susceptibility-sensitive sequence where available.
• Contrast-enhanced imaging where tumour or another differential diagnosis is considered.
• Thin axial imaging through the lesion.
• Whole-spine screening where clinically indicated.
• All previous MRI studies for comparison.

Axial imaging is essential because surgical accessibility depends heavily on whether the lesion is dorsal, lateral, central or ventral and whether it reaches the pial surface.

• MRI obtained at or near symptom onset.
• Evidence of acute or subacute blood products.
• Spinal-cord expansion, oedema or mass effect.
• Associated syrinx or central cavitation.
• Serial imaging showing evolution of haemorrhage.
• Alternative sources of myelopathy or haemorrhage already assessed.

Mixed-age blood products or changing signal within a cavernoma do not by themselves prove a new clinically symptomatic haemorrhage.

• Cervical, thoracic, epiconus, conus or other exact level.
• Dorsal, dorsolateral, lateral, central or ventral axial position.
• Pial, exophytic or fully intramedullary relationship.
• Cranio-caudal lesion length.
• Relationship to dorsal columns, corticospinal tracts, spinothalamic pathways and anterior median structures.
• Surface discoloration, hemosiderin or natural sulcus information where documented.
• Associated developmental venous anomaly or vascular finding.

• Urinary urgency, retention, catheterization, incontinence and infection history.
• Bowel control, constipation and evacuation programme.
• Sexual-function and autonomic symptoms where relevant.
• Neuropathic, radicular or central pain characteristics.
• Spasticity and medication history.
• Urology, urodynamic, pain or rehabilitation assessments where performed.

• Operative report and exposure level.
• Laminectomy, laminoplasty or other access.
• Midline myelotomy, dorsal-root-entry-zone or other surgical corridor.
• Intraoperative ultrasound, navigation and monitoring data.
• Whether gross-total resection was believed to be achieved.
• Histopathology.
• Early postoperative MRI and later surveillance studies.
• Postoperative weakness, sensory change, pain, sphincter change or other complications.

• Motor-evoked and somatosensory-evoked potential baseline.
• D-wave monitoring where used.
• Changes during myelotomy, dissection and closure.
• Actions taken in response to signal change.
• Immediate postoperative neurological examination.
• Correlation between monitoring and later functional outcome.

Monitoring supports intraoperative decision-making but does not guarantee preservation of every spinal function and should be interpreted by the operating team.

• Timing and quality of postoperative MRI.
• Location and size of any suspected residual component.
• New haemorrhage, lesion growth or progressive symptoms.
• Postoperative gliosis and altered surgical corridor.
• Reason complete removal was not achieved where documented.
• Previous and current specialist recommendations.

• Age at presentation and developmental or school impact.
• Brain MRI and number of intracranial lesions.
• Family history of CCM or unexplained CNS haemorrhage.
• KRIT1/CCM1, CCM2 and PDCD10/CCM3 testing where performed.
• Previous genetic counselling.
• Prior cranial or spinal radiotherapy.
• Pediatric-to-adult transition planning.

• Physical and occupational therapy assessments.
• Walking video, aid use and transfer status.
• Hand function, self-care and work limitations.
• Neuropathic pain and spasticity management.
• Pressure-injury and thrombosis-risk information in severe immobility.
• Access to local spinal neurosurgery, rehabilitation, urology and emergency MRI.
• Family or caregiver support and travel fitness.

A typical spinal cavernous malformation is a low-flow intramedullary lesion and is usually angiographically occult. Haemorrhagic ependymoma, other intramedullary tumours, spinal AVM and perimedullary fistula can mimic aspects of its presentation. Enhancement pattern, solid tumour component, oedema, syrinx, flow voids and vascular imaging help define the differential diagnosis.

A truly asymptomatic spinal CCM does not automatically require preventive surgery. Degenerative spinal disease, peripheral neuropathy, musculoskeletal pain and other myelopathies may coexist. Symptoms should be anatomically and temporally matched to the lesion before treatment is justified.

A symptomatic haemorrhage combines a new acute or subacute spinal neurological event with imaging evidence of recent bleeding in or around the lesion. Changing internal blood products or lesion signal without a corresponding clinical event are not equivalent to symptomatic haemorrhage. This distinction influences future-risk and surgical discussion.

Acute haemorrhage can cause sudden weakness, sensory level, pain, gait loss or sphincter dysfunction. Some spontaneous neurological recovery may occur as blood products and oedema evolve, while rapid deterioration or severe cord compression can increase urgency. The early examination does not always predict the eventual untreated or postoperative baseline.

Repeated small haemorrhages or chronic lesion effects can produce stepwise or gradual decline. Serial neurological examination is as important as MRI. Progressive weakness, proprioceptive loss, gait dysfunction, spasticity or bladder change may strengthen the case for intervention, but other causes of deterioration should still be assessed.

A dorsal, dorsolateral, pial or exophytic lesion may provide a shorter surgical route and can be visible through hemosiderin or surface discoloration. This can improve accessibility but does not make surgery risk-free. A single function-limiting event, progressive decline or repeated haemorrhage may justify resection review when the expected corridor is favourable.

Ventral, central or deeply embedded lesions may require traversal of functioning spinal tissue or a more complex surgical approach. Their operative threshold may be higher, although recurrent haemorrhage, severe progressive deficit or a natural corridor created by the lesion can alter the balance. These cases benefit from highly specialized spinal vascular expertise.

Cervical lesions can affect hand function, all four limbs, proprioception, gait, bladder function and—at high levels—respiration. Even a small operative or haemorrhagic injury can substantially alter independence. Documentation should include fine motor ability, transfers, walking, sphincter function and respiratory symptoms.

Thoracic lesions commonly affect leg strength, sensory level, spasticity, gait, neuropathic trunk or leg pain and bladder, bowel or sexual function. Recovery may be incomplete even when strength improves. Proprioception, pain, endurance and sphincter function should be followed separately.

Conus and epiconus CCMs can affect lower-motor-neuron function, saddle sensation, bladder emptying, bowel control and sexual function. A small further injury may cause disproportionate autonomic disability. The review should distinguish conus symptoms from cauda equina, peripheral nerve and lumbar degenerative disorders.

Children have a longer lifetime risk horizon and may face developmental, school and mobility effects. Surgery also carries risks related to spinal alignment, repeated imaging and long-term rehabilitation. Familial and intracranial CCM assessment and transition planning are important in pediatric cases.

A spinal lesion may occur as part of multifocal or familial CCM. Brain MRI, family history and genetic counselling can be relevant. The principal genes are KRIT1/CCM1, CCM2 and PDCD10/CCM3. Genetic status does not by itself determine whether one spinal lesion should be operated on.

Microsurgery aims to remove the lesion while minimizing additional spinal-cord injury. Exposure may involve laminectomy or laminoplasty, intraoperative ultrasound, lesion-specific myelotomy and neurophysiological monitoring. Risks include new weakness, sensory loss, proprioceptive dysfunction, pain, sphincter deterioration, CSF leak, infection, spinal deformity and permanent disability.

Timing depends on neurological trajectory, haemorrhage, oedema, lesion location and surgical visibility. Immediate surgery is not required for every haemorrhage, while rapid deterioration, severe deficit, mass effect or a favourable acute corridor can create greater urgency. Delaying may allow partial recovery and clearer tissue planes in some cases, but also leaves the patient exposed to further events.

Motor, sensory and D-wave monitoring can support surgical decisions but cannot guarantee preservation of all function. Complete resection may reduce the risk from residual lesion, but aggressive dissection should not override spinal-cord safety. Early postoperative MRI helps assess residual cavernoma, although blood and surgical change can complicate interpretation.

Residual CCM can later enlarge or rebleed. Reoperation is often more complex because of gliosis and altered anatomy. Management depends on the residual’s size, location, symptoms, haemorrhage history and the risk of another surgical corridor. “Surgery completed” is not equivalent to confirmed gross-total resection.

A spinal cavernous malformation is not a high-flow shunt and generally has no embolizable nidus or fistula point. Endovascular embolization is therefore not a standard treatment. Spinal radiosurgery is also not established as a standard first-line therapy because the lesion remains present, the effect is delayed and the spinal cord is vulnerable to radiation injury.

Observation is an active plan with a documented neurological baseline, clear triggers for urgent MRI and specialist-defined follow-up. Meaningful outcomes include walking, hand function, sensation, pain, spasticity, bladder, bowel, sexual function, independence and quality of life—not MRI appearance or muscle strength alone. Rehabilitation is part of both conservative and postoperative pathways.